CD28 and neoplasm: CTLA-4 ligands, such as B7 molecules, are highly expressed by TAMs and DCs in the tumour microenvironment and their expression directly correlates with the reduction of anti-tumour T cell by inhibiting CD28 in several tumour models [192, 193].